Anemia
News
Gene therapy proves effective in SCD patient
Researchers have reported a favorable outcome in the first patient with severe sickle cell disease (SCD) to receive gene therapy in the HGB-205...
From the Journals
Stable response in sickle cell disease patient treated with gene therapy
A case study reveals clinical remission and ongoing healthy hemoglobin production 15 months after treatment for sickle cell disease.
From the Journals
In beta thalassemia major, liver stiffness declines with deferasirox
For patients with beta thalassemia major, long-term chelation with deferasirox led to significant improvements in liver stiffness.
From the Journals
Early mortality risk factors in adult sickle cell disease support ECG screening
The largest combined analysis of mortality risk factors for adult sickle cell disease patients in the era of hydroxyurea use confirms previous...
From the Journals
Thrombotic microangiopathy may signal IV drug abuse
Thrombotic microangiopathy may be triggered by IV drug abuse of extended-release oxymorphone hydrochloride tablets.
From the Journals
Testosterone Trials’ cardiac, cognitive results disappoint
Testosterone treatment may have beneficial effects on unexplained anemia or bone density, but may increase coronary artery plaque and offer no...
News
Model illustrates progression to MDS, AML
Researchers say they have created a model that shows the step-by-step progression from normal blood cells to acute myeloid leukemia (AML). The...
News
Understanding a rare hemoglobin mutation
Smoking can prevent anemia in individuals with a rare hemoglobin mutation, according to research published in the Journal of Biological Chemistry...
News
Study reveals patterns of ED use in SCD patients
Photo courtesy of St.
News
Genetic profiling can guide HSCT in MDS, team says
Genetic profiling can be used to determine which patients with myelodysplastic syndrome (MDS) are likely to benefit from allogeneic hematopoietic...
News
FDA approves IVIG product for PI and chronic ITP
The US Food and Drug Administration (FDA) has approved an intravenous immunoglobulin (IVIG) product (Gammaplex® 10%) for the treatment of primary...